174 related articles for article (PubMed ID: 35948758)
1. p73 isoforms meet evolution of metastasis.
Logotheti S; Pavlopoulou A; Marquardt S; Takan I; Georgakilas AG; Stiewe T
Cancer Metastasis Rev; 2022 Dec; 41(4):853-869. PubMed ID: 35948758
[TBL] [Abstract][Full Text] [Related]
2. Role of p73 in malignancy: tumor suppressor or oncogene?
Stiewe T; Pützer BM
Cell Death Differ; 2002 Mar; 9(3):237-45. PubMed ID: 11859406
[TBL] [Abstract][Full Text] [Related]
3. The role of the TP73 gene and its transcripts in neuro-oncology.
Jancalek R
Br J Neurosurg; 2014 Oct; 28(5):598-605. PubMed ID: 24742294
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of p73 and p53 regulation and effector functions.
Fang L; Lee SW; Aaronson SA
J Cell Biol; 1999 Nov; 147(4):823-30. PubMed ID: 10562283
[TBL] [Abstract][Full Text] [Related]
5. p73 in apoptosis.
Stiewe T; Pützer BM
Apoptosis; 2001 Dec; 6(6):447-52. PubMed ID: 11595834
[TBL] [Abstract][Full Text] [Related]
6. The cell type-specific effect of TAp73 isoforms on the cell cycle and apoptosis.
Holcakova J; Ceskova P; Hrstka R; Muller P; Dubska L; Coates PJ; Palecek E; Vojtesek B
Cell Mol Biol Lett; 2008; 13(3):404-20. PubMed ID: 18350258
[TBL] [Abstract][Full Text] [Related]
7. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
Murray-Zmijewski F; Lane DP; Bourdon JC
Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
[TBL] [Abstract][Full Text] [Related]
8. TP53 family members and human cancers.
Bénard J; Douc-Rasy S; Ahomadegbe JC
Hum Mutat; 2003 Mar; 21(3):182-91. PubMed ID: 12619104
[TBL] [Abstract][Full Text] [Related]
9. Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.
Concin N; Becker K; Slade N; Erster S; Mueller-Holzner E; Ulmer H; Daxenbichler G; Zeimet A; Zeillinger R; Marth C; Moll UM
Cancer Res; 2004 Apr; 64(7):2449-60. PubMed ID: 15059898
[TBL] [Abstract][Full Text] [Related]
10. IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo.
Venkatanarayan A; Raulji P; Norton W; Chakravarti D; Coarfa C; Su X; Sandur SK; Ramirez MS; Lee J; Kingsley CV; Sananikone EF; Rajapakshe K; Naff K; Parker-Thornburg J; Bankson JA; Tsai KY; Gunaratne PH; Flores ER
Nature; 2015 Jan; 517(7536):626-30. PubMed ID: 25409149
[TBL] [Abstract][Full Text] [Related]
11. The p53 family member p73 in the regulation of cell stress response.
Rozenberg JM; Zvereva S; Dalina A; Blatov I; Zubarev I; Luppov D; Bessmertnyi A; Romanishin A; Alsoulaiman L; Kumeiko V; Kagansky A; Melino G; Ganini C; Barlev NA
Biol Direct; 2021 Nov; 16(1):23. PubMed ID: 34749806
[TBL] [Abstract][Full Text] [Related]
12. Diverse p63 and p73 isoforms regulate Δ133p53 expression through modulation of the internal TP53 promoter activity.
Marcel V; Petit I; Murray-Zmijewski F; Goullet de Rugy T; Fernandes K; Meuray V; Diot A; Lane DP; Aberdam D; Bourdon JC
Cell Death Differ; 2012 May; 19(5):816-26. PubMed ID: 22075982
[TBL] [Abstract][Full Text] [Related]
13. p63 and p73: roles in development and tumor formation.
Moll UM; Slade N
Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
[TBL] [Abstract][Full Text] [Related]
14. p53 Family isoforms.
Bourdon JC
Curr Pharm Biotechnol; 2007 Dec; 8(6):332-6. PubMed ID: 18289041
[TBL] [Abstract][Full Text] [Related]
15. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family.
Flores ER; Sengupta S; Miller JB; Newman JJ; Bronson R; Crowley D; Yang A; McKeon F; Jacks T
Cancer Cell; 2005 Apr; 7(4):363-73. PubMed ID: 15837625
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific expression of p73 and p63 isoforms in human tissues.
Marshall CB; Beeler JS; Lehmann BD; Gonzalez-Ericsson P; Sanchez V; Sanders ME; Boyd KL; Pietenpol JA
Cell Death Dis; 2021 Jul; 12(8):745. PubMed ID: 34315849
[TBL] [Abstract][Full Text] [Related]
17. Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivo.
Emmrich S; Wang W; John K; Li W; Pützer BM
Mol Cancer; 2009 Aug; 8():61. PubMed ID: 19671150
[TBL] [Abstract][Full Text] [Related]
18. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
Muttray AF; Cox RL; Reinisch CL; Baldwin SA
Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
[TBL] [Abstract][Full Text] [Related]
19. Regulating p73 isoforms in human tumours.
Coates PJ
J Pathol; 2006 Dec; 210(4):385-9. PubMed ID: 17044134
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of Functional Pleiotropy of p73 in Cancer and Beyond.
Logotheti S; Richter C; Murr N; Spitschak A; Marquardt S; Pützer BM
Front Cell Dev Biol; 2021; 9():737735. PubMed ID: 34650986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
